- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07820696
Effect of Oral Laxative Use Before Colorectal Surgery on Intraoperative Surgical Difficulty (OLAX-CRC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mechanical bowel preparation is commonly used before elective colorectal surgery. Although its effects on postoperative outcomes have been widely investigated, limited evidence is available regarding the effect of oral laxatives on intraoperative small-bowel distension and technical difficulty during laparoscopic colorectal surgery. Increased intraluminal fluid following oral laxative administration may lead to small-bowel distension, potentially impairing surgical exposure and increasing the need for bowel manipulation.
In this study, small-bowel diameter will be assessed intraoperatively using a standardized measurement method after laparoscopic access and establishment of pneumoperitoneum. Jejunal diameter will be measured approximately 50 cm distal to the ligament of Treitz, and ileal diameter approximately 20 cm proximal to the ileocecal valve. Measurements will be performed in the transverse plane without applying mesenteric tension and, when feasible, the mean of two measurements will be recorded. At the end of the operation, the operating surgeon will assess overall operative difficulty using a Likert-type scale ranging from very easy to very difficult. This pilot study is intended to provide preliminary evidence for the design of future adequately powered studies and to support the evaluation of current bowel-preparation practices.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: İbrahim Doğan
- Phone Number: +905313884966
- Email: dogan_203@hotmail.com
Study Locations
-
-
Van
-
Van, Van, Turkey (Türkiye), 65300
- Recruiting
- University of Health Sciences Türkiye, Van Training and Research Hospital
-
Contact:
- İbrahim Doğan
- Phone Number: +905313884966
- Email: dogan_203@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- Scheduled for elective laparoscopic colorectal resection
- American Society of Anesthesiologists (ASA) physical status I-III
- Able and willing to provide written informed consent
Exclusion Criteria:
- Requirement for emergency surgery
- Mechanical intestinal obstruction, gastrointestinal perforation, or generalized peritonitis
- Anticipated extensive intra-abdominal adhesions
- Active inflammatory bowel disease
- Pregnancy
- Serious systemic disease constituting a contraindication to oral laxative use
- Inability to perform standardized intraoperative small-bowel diameter measurements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oral Laxative Plus Rectal Enema
Participants assigned to this arm will receive preoperative bowel preparation consisting of an oral laxative combined with a rectal enema before elective laparoscopic colorectal surgery.
|
Participants assigned to the experimental arm will receive an oral laxative as part of preoperative mechanical bowel preparation, in addition to a rectal enema, before elective laparoscopic colorectal surgery.
The oral laxative will be administered according to the institution's standard preoperative bowel preparation protocol.
Participants in both study arms will receive a rectal enema as part of preoperative bowel preparation before elective laparoscopic colorectal surgery.
Participants in the comparator arm will receive the rectal enema without an oral laxative.
|
|
Active Comparator: Rectal Enema Alone
Participants assigned to this arm will receive preoperative bowel preparation consisting of a rectal enema alone, without an oral laxative, before elective laparoscopic colorectal surgery.
|
Participants in both study arms will receive a rectal enema as part of preoperative bowel preparation before elective laparoscopic colorectal surgery.
Participants in the comparator arm will receive the rectal enema without an oral laxative.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative Jejunal Diameter
Time Frame: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
|
Jejunal diameter will be measured in centimeters approximately 50 cm distal to the ligament of Treitz, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension.
When feasible, two measurements will be obtained and their mean will be recorded.
|
Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
|
|
Intraoperative Ileal Diameter
Time Frame: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
|
Ileal diameter will be measured in centimeters approximately 20 cm proximal to the ileocecal valve, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension.
When feasible, two measurements will be obtained and their mean will be recorded.
|
Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative Difficulty Score
Time Frame: At the end of surgery, on the day of the procedure
|
Overall operative difficulty will be assessed by the operating surgeon at the end of the procedure using a 5-point Likert scale: 1 = very easy, 2 = easy, 3 = moderate, 4 = difficult, and 5 = very difficult.
Higher scores indicate greater operative difficulty.
|
At the end of surgery, on the day of the procedure
|
|
Estimated Intraoperative Blood Loss
Time Frame: Intraoperatively, on the day of surgery
|
The estimated volume of blood lost during surgery, as recorded in the operative and anesthesia records.
|
Intraoperatively, on the day of surgery
|
|
Incidence of Intraoperative Serosal Injury
Time Frame: Intraoperatively, on the day of surgery
|
The number of participants who experience an unintended serosal injury during surgery, as documented in the operative record.
|
Intraoperatively, on the day of surgery
|
|
Incidence of Intraoperative Organ Injury
Time Frame: Intraoperatively, on the day of surgery
|
The number of participants who experience an unintended injury to an intra-abdominal organ during surgery, as documented in the operative record.
|
Intraoperatively, on the day of surgery
|
|
Incidence of Intraoperative Bleeding Requiring Intervention
Time Frame: Intraoperatively, on the day of surgery
|
The number of participants who experience intraoperative bleeding requiring an additional hemostatic intervention beyond routine surgical hemostasis.
|
Intraoperatively, on the day of surgery
|
|
Requirement for an Additional Laparoscopic Port
Time Frame: Intraoperatively, on the day of surgery
|
The number of participants in whom placement of at least one additional laparoscopic port beyond the planned port configuration is required to complete the procedure.
|
Intraoperatively, on the day of surgery
|
|
Conversion From Laparoscopic to Open Surgery
Time Frame: Intraoperatively, on the day of surgery
|
The number of participants whose planned laparoscopic procedure is converted to an open surgical approach.
|
Intraoperatively, on the day of surgery
|
|
Incidence of Any Postoperative Complication Within 30 Days
Time Frame: From the day of surgery through postoperative day 30
|
The number of participants who experience at least one surgery-related postoperative complication within 30 days after surgery.
Each participant will be counted once, regardless of the number of complications experienced.
|
From the day of surgery through postoperative day 30
|
|
Incidence of Anastomotic Leakage Within 30 Days
Time Frame: From the day of surgery through postoperative day 30
|
The number of participants who develop an anastomotic leak within 30 days after surgery, as documented by clinical, radiological, endoscopic, operative, or drainage findings.
|
From the day of surgery through postoperative day 30
|
|
Incidence of Surgical Site Infection Within 30 Days
Time Frame: From the day of surgery through postoperative day 30
|
The number of participants who develop a surgical site infection within 30 days after surgery, including superficial incisional, deep incisional, or organ/space infection.
|
From the day of surgery through postoperative day 30
|
|
Incidence of Postoperative Ileus Within 30 Days
Time Frame: From the day of surgery through postoperative day 30
|
The number of participants who develop postoperative ileus within 30 days after surgery, as documented in the medical record based on delayed recovery or interruption of gastrointestinal function.
|
From the day of surgery through postoperative day 30
|
|
Time Required for Bowel Manipulation and Displacement
Time Frame: Intraoperatively, on the day of surgery
|
The time required to manipulate the bowel and displace it from the operative field during surgery.
|
Intraoperatively, on the day of surgery
|
|
Time Required for Intraoperative Bowel Diameter Measurements
Time Frame: Intraoperatively, on the day of surgery
|
The time required to perform intraoperative measurements of the jejunal and ileal diameters.
|
Intraoperatively, on the day of surgery
|
|
Time Required to Complete the Anastomosis
Time Frame: Intraoperatively, on the day of surgery
|
The time from initiation of anastomosis construction to completion of the anastomosis during surgery.
|
Intraoperatively, on the day of surgery
|
|
Total Operation Time
Time Frame: Intraoperatively, on the day of surgery
|
The total duration of the surgical procedure, defined as the time from skin incision to completion of skin closure.
|
Intraoperatively, on the day of surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026/05-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.